KYUNG CHAN PARK

Dr. KYUNG CHAN PARK

Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Cell
Verified
Journal Article
Closed access
DLDong Chul Lee
Dong Chul Lee
HSHyun Ahm Sohn
Hyun Ahm Sohn
ZPZee-Yong Park
Zee-Yong Park
SOSangho Oh
Sangho Oh
YKYun Kyung Kang
Yun Kyung Kang
YYYoung Il Yeom
Young Il Yeom

9 March 2017 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
SYSuk‐Jin Yang
Suk‐Jin Yang
YPYoung Soo Park
Young Soo Park
JCJung Hee Cho
Jung Hee Cho
BMByul Moon
Byul Moon
HAHyun‐Jung An
Hyun‐Jung An
YYYoung Il Yeom
Young Il Yeom

20 June 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
YPYoung Soo Park
Young Soo Park
DKDong Joon Kim
Dong Joon Kim
HKHan Koo
Han Koo
SJSe Hwan Jang
Se Hwan Jang
YYYeon-Mi You
Yeon-Mi You
YYYoung Il Yeom
Young Il Yeom
AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth

1 August 2015 in Experimental Cell Research
Verified
Journal Article
Closed access
DKDong Joon Kim
Dong Joon Kim
YPYoung Soo Park
Young Soo Park
MKMin Gu Kang
Min Gu Kang
YYYeon-Mi You
Yeon-Mi You
YJYuri Jung
Yuri Jung
YYYoung Il Yeom
Young Il Yeom

15 October 2013 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
TKTae Woo Kim
Tae Woo Kim
YKYun Kyung Kang
Yun Kyung Kang
ZPZee Yong Park
Zee Yong Park
YKYoung-Ho Kim
Young-Ho Kim
SHSeong Woo Hong
Seong Woo Hong
KPKYUNG CHAN PARK
KYUNG CHAN PARK
SH3RF (SH3-domain-containing RING finger protein) family members, SH3RF1-3, are multidomain scaffold proteins involved in promoting cell survival and apoptosis. In this report, we show that SH3RF2 is an oncogene product that is overexpressed in human cancers and regulates p21-activated kinase 4 (PAK4) protein stability. Immunohistochemical analysis of 159 colon cancer tissues showed that SH3RF2 expression levels are frequently elevated in cancer tissues and significantly correlate with poor prognostic indicators, including increased invasion, early recurrence and poor survival rates. We also demonstrated that PAK4 protein is degraded by the ubiquitin–proteasome system and that SH3RF2 inhibits PAK4 ubiquitination via physical interaction-mediated steric hindrance, which results in the upregulation of PAK4 protein. Moreover, ablation of SH3RF2 expression attenuates TRADD (TNFR-associated death domain) recruitment to tumor necrosis factor-α (TNF-α) receptor 1 and hinders downstream signals, thereby inhibiting NF-κB (nuclear factor-kappaB) activity and enhancing caspase-8 activity, in the context of TNF-α treatment. Notably, ectopic expression of SH3RF2 effectively prevents apoptosis in cancer cells and enhances cell migration, colony formation and tumor growth in vivo . Taken together, our results suggest that SH3RF2 is an oncogene that may be a definitive regulator of PAK4. Therefore, SH3RF2 may represent an effective therapeutic target for cancer treatment.

6 January 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
KKKyung Rok Kim
Kyung Rok Kim
KKKyung A. Kim
Kyung A. Kim
JPJoon Sung Park
Joon Sung Park
JJJun Young Jang
Jun Young Jang
YCYuri Choi
Yuri Choi
Byung Woo HanByung Woo Han
Byung Woo Han
The N-Myc downstream-regulated gene (NDRG) family belongs to the α/β-hydrolase fold and is known to exert various physiologic functions in cell proliferation, differentiation, and hypoxia-induced cancer metabolism. In particular, NDRG3 is closely related to proliferation and migration of prostate cancer cells, and recent studies reported its implication in lactate-triggered hypoxia responses or tumorigenesis. However, the underlying mechanism for the functions of NDRG3 remains unclear. Here, we report the crystal structure of human NDRG3 at 2.2 Å resolution, with six molecules in an asymmetric unit. While NDRG3 adopts the α/β-hydrolase fold, complete substitution of the canonical catalytic triad residues to non-reactive residues and steric hindrance around the pseudo-active site seem to disable the α/β-hydrolase activity. While NDRG3 shares a high similarity to NDRG2 in terms of amino acid sequence and structure, NDRG3 exhibited remarkable structural differences in a flexible loop corresponding to helix α6 of NDRG2 that is responsible for tumor suppression. Thus, this flexible loop region seems to play a distinct role in oncogenic progression induced by NDRG3. Collectively, our studies could provide structural and biophysical insights into the molecular characteristics of NDRG3.